Cargando…

Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF-1α-Dependent and Independent Mechanisms in Heart Failure Rats after Acute Myocardial Infarction

The present study is aimed at investigating whether Qiliqiangxin (QL) could regulate myocardial energy metabolism in heart failure rats after acute myocardial infarction (AMI) and further exploring the underlying mechanisms. AMI was established by ligating the left anterior descending coronary arter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yanyan, Fu, Mingqiang, Wang, Jingfeng, Zhang, Jingjing, Han, Xueting, Song, Yu, Fan, Yuyuan, Hu, Kai, Zhou, Jingmin, Ge, Junbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306086/ https://www.ncbi.nlm.nih.gov/pubmed/32626732 http://dx.doi.org/10.1155/2020/1276195

Ejemplares similares

Qiliqiangxin attenuates hypoxia‐induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF‐1α‐dependent glycolysis
por: Wang, Yanyan, et al.
Publicado: (2018)

Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats
por: Wang, Jingfeng, et al.
Publicado: (2017)

Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG‐1/ErbB‐PI3K/Akt/mTOR pathway
por: Wang, Jingfeng, et al.
Publicado: (2017)

Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6
por: Zhou, Jingmin, et al.
Publicado: (2015)

Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction
por: Cheng, Wenkun, et al.
Publicado: (2020)

Protective Effect of Qiliqiangxin Capsule on Energy Metabolism and Myocardial Mitochondria in Pressure Overload Heart Failure Rats
por: Zhang, Junfang, et al.
Publicado: (2013)

Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
por: Tao, Lichan, et al.
Publicado: (2015)

Effects of Adiponectin on Diastolic Function in Mice Underwent Transverse Aorta Constriction
por: Han, Xueting, et al.
Publicado: (2019)

Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration
por: Tao, Lichan, et al.
Publicado: (2013)

Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload–induced Cardiac Hypertrophy and Remodeling in Male Mice
por: Ye, Yong, et al.
Publicado: (2015)

Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
por: Chen, Huiyang, et al.
Publicado: (2019)

A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach
por: Fu, Junzeng, et al.
Publicado: (2018)

The Electrophysiological Effects of Qiliqiangxin on Cardiac Ventricular Myocytes of Rats
por: Wei, Yidong, et al.
Publicado: (2013)

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure
por: Lu, Yingdong, et al.
Publicado: (2022)

Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
por: Sun, Xutao, et al.
Publicado: (2020)

Qiliqiangxin reduced cardiomyocytes apotosis and improved heart function in infarcted heart through Pink1/Parkin -mediated mitochondrial autophagy
por: Zhou, Junyang, et al.
Publicado: (2020)

Differential microRNA expression profiles and bioinformatics analysis between young and aging spontaneously hypertensive rats
por: Wang, Jingfeng, et al.
Publicado: (2018)

Regulation of Cardiac-Specific Proteins Expression by Moderate-Intensity Aerobic Exercise Training in Mice With Myocardial Infarction Induced Heart Failure Using MS-Based Proteomics
por: Mi, Shouling, et al.
Publicado: (2021)

Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway
por: Zhang, Qian, et al.
Publicado: (2020)

The Efficacy and Safety of a Qiliqiangxin Capsule Combined with Sacubitril/Valsartan in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Chen, Wensheng, et al.
Publicado: (2023)

Increased ratio of sST2/LVMI predicted cardiovascular mortality and heart failure rehospitalization in heart failure with reduced ejection fraction patients: a prospective cohort study
por: Li, Fuhai, et al.
Publicado: (2021)

Integrating Pharmacokinetics Study, Network Analysis, and Experimental Validation to Uncover the Mechanism of Qiliqiangxin Capsule Against Chronic Heart Failure
por: Zhang, Yu, et al.
Publicado: (2019)

Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry)
por: Jin, Xuejuan, et al.
Publicado: (2019)

Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
por: Wu, Xiaodong, et al.
Publicado: (2021)

Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST)
por: Yao, Wenming, et al.
Publicado: (2020)

Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats
por: Wang, Hui, et al.
Publicado: (2017)

Qiliqiangxin Affects L Type Ca(2+) Current in the Normal and Hypertrophied Rat Heart
por: Wei, Yidong, et al.
Publicado: (2012)

Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis
por: Qin, Yating, et al.
Publicado: (2022)

Gastrin mediates cardioprotection through angiogenesis after myocardial infarction by activating the HIF-1α/VEGF signalling pathway
por: Wang, Rui, et al.
Publicado: (2021)

The promotion of sestrin2/AMPK signaling by HIF-1α overexpression enhances the damage caused by acute myocardial infarction
por: Wang, Jie, et al.
Publicado: (2023)

Association of Small Intestinal Bacterial Overgrowth With Heart Failure and Its Prediction for Short‐Term Outcomes
por: Song, Yu, et al.
Publicado: (2021)

Aggravated myocardial infarction-induced cardiac remodeling and heart failure in histamine-deficient mice
por: Chen, Jinmiao, et al.
Publicado: (2017)

A Comparison of the Efficacy of Surgical Renal Denervation and Pharmacologic Therapies in Post-Myocardial Infarction Heart Failure
por: Hu, Jialu, et al.
Publicado: (2014)

Hypoxia-Inducible Factor 1 alpha (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Pathway Participates in Angiogenesis of Myocardial Infarction in Muscone-Treated Mice: Preliminary Study
por: Du, Yingqiang, et al.
Publicado: (2018)

HIF-1α in myocardial ischemia-reperfusion injury
por: Zheng, Jie, et al.
Publicado: (2021)

Latifolin protects against myocardial infarction by alleviating myocardial inflammatory via the HIF-1α/NF-κB/IL-6 pathway
por: Lai, Xiao-Xiao, et al.
Publicado: (2020)

HIF‐1α‐induced up‐regulation of microRNA‐126 contributes to the effectiveness of exercise training on myocardial angiogenesis in myocardial infarction rats
por: Song, Wei, et al.
Publicado: (2020)

Study protocol: Traditional Chinese Medicine (TCM) syndrome differentiation for heart failure patients and its implication for long-term therapeutic outcomes of the Qiliqiangxin capsules
por: Leung, Alice Yeuk Lan, et al.
Publicado: (2021)

HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis
por: Sun, Jiacheng, et al.
Publicado: (2020)

HIF-1α-regulated lncRNA-TUG1 promotes mitochondrial dysfunction and pyroptosis by directly binding to FUS in myocardial infarction
por: Wang, Yong-Wang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ii1q3c2hopmm5h39tgou06vml3